Teladoc Health, Inc.·4

Mar 3, 4:10 PM ET

Nueno Carlos 4

4 · Teladoc Health, Inc. · Filed Mar 3, 2026

Insider Transaction Report

Form 4
Period: 2026-02-27
Nueno Carlos
President, International
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-27+3,10130,276 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-27+4,55634,832 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-27+34,86769,699 total
  • Exercise/Conversion

    Common Stock

    [F2]
    2026-02-27+1,06170,760 total
  • Sale

    Common Stock

    [F3]
    2026-03-02$5.12/sh20,165$103,18450,595 total
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F4]
    2026-02-273,1010 total
    Common Stock (3,101 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F5]
    2026-02-274,55618,226 total
    Common Stock (4,556 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F1][F6]
    2026-02-2734,86769,735 total
    Common Stock (34,867 underlying)
  • Exercise/Conversion

    Performance Stock Units

    [F2][F7]
    2026-02-271,0610 total
    Common Stock (1,061 underlying)
  • Award

    Restricted Stock Units

    [F8][F9]
    2026-03-01+173,010173,010 total
    Common Stock (173,010 underlying)
Footnotes (9)
  • [F1]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F2]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
  • [F4]On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F5]On March 19, 2024, the reporting person was granted 54,675 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
  • [F6]On March 1, 2025, the reporting person was granted 104,602 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F7]On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F8]Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
  • [F9]One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact|2026-03-03

Documents

1 file
  • 4
    wk-form4_1772572244.xmlPrimary

    FORM 4